April 13, 2023
Federal officials are warning the public about an emerging threat in the nation’s opioid crisis.
This week, the Drug Enforcement Administration (DEA) reported on the rise of illicit fentanyl spiked with the animal tranquilizer xylazine, a powerful sedative that the FDA has approved for veterinary use. The agency has seized xylazine and fentanyl in 48 of 50 states.
“Xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier,” said DEA Administrator Anne Milgram.
Here's what you need to know:
Providers and patients should report adverse events related to the drug to the FDA’s MedWatch Adverse Event Reporting program.
Additional information from the FDA and DEA is available online.
Tags: Public Health | Behavioral Health
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.